People | May 01, 2026
Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA
Tamir brings more than 20 years of experience in the medical technology sector
Tamir brings more than 20 years of experience in the medical technology sector
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
Aims to boost speed & precision in patient care
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
The system is powered by BrainSense technology, which has received approval from USFDA
Subscribe To Our Newsletter & Stay Updated
